Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Solace Therapeutics logo — Empowering patients with innovative and non-invasive treatme...

Solace Therapeutics

Empowering patients with innovative and non-invasive treatments for bladder health, while ensuring comfort and quality of life.

Founded 1997 Series B Total: $36.00M Health Care, Health and Wellness +1

General Information

Company Name Solace Therapeutics
Founded Year 1997
Industries Health Care, Health and Wellness, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Solace Therapeutics. To contact Solace Therapeutics, visit solacetx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Solace Therapeutics

Solace Therapeutics is a health care startup that focuses on developing and marketing innovative and non-invasive treatments for prevalent bladder disorders. The company's slogan "Empowering patients with innovative and non-invasive treatments for bladder health, while ensuring comfort and quality of life," encapsulates its mission. Since its foundation in 1997, Solace Therapeutics has been committed to enhancing patient quality of life by addressing conditions such as stress urinary incontinence, overactive bladder, male voiding dysfunction, and lower urinary tract symptoms. The company's latest milestone was the Series B investment it secured on 01 April 2020, with backing from Portfolia and Jennifer Fried. Solace Therapeutics' innovative technology is designed to offer patients a non-invasive therapy option that can be administered in an office setting, eliminating the need for anesthesia or surgery. This pioneering approach mitigates the side effects often associated with conventional drug and surgical therapies, allowing patients to maintain their regular lifestyle before and after treatment. Furthermore, the non-permanent nature of the therapy provides an added layer of flexibility, as it can be reversed at any time. Overall, Solace Therapeutics' commitment to advancing non-invasive treatments for bladder health represents a promising opportunity for investors seeking to support innovative solutions in the health care sector.

Taxonomy: bladder health, office-based treatments, non-invasive treatments, patient comfort, quality of life, stress urinary incontinence, overactive bladder, male voiding dysfunction, lower urinary tract symptoms, innovative therapies, non-surgical treatments, reversible treatments, patient-focused

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Undisclosed 2
Portfolia
Portfolia, Jennifer Fried
01 Apr 2020
Venture Round $13.00M -
06 Sep 2016
Venture Round $13.00M 1
New Enterprise Associates
New Enterprise Associates
01 Jun 2014
Venture Round $7.00M 3
New Enterprise Associates Saints Capital Spray Venture Partners
New Enterprise Associates, Saints Capital +1
28 Mar 2012
Series B $3.00M 2
Boston Scientific Spray Venture Partners
Boston Scientific, Spray Venture Partners
09 Aug 2006

Solace Therapeutics Alternatives & Competitors

Solace Therapeutics vs
Axonics, Inc.
Axonics, Inc. United States

Experience the Difference, Experience Axonics

Post-IPO Equity
703 employees
Health Care, Medical Devices
Solace Therapeutics vs
The Urology Group
The Urology Group United States

25 years as Greater Cincinnati's Largest Independent Urology Group with 12 Locations to Serve You Be...

230 employees
Health Care, Health and Wellness
Solace Therapeutics vs
Tesla Medical s.r.o.
Tesla Medical s.r.o. Czech Republic

We create technology that allows non-invasive treatment of chronic diseases using neuromodulation.

Series A
2 employees
Health Care, Manufacturing

FAQ About Solace Therapeutics

Empowering patients with innovative and non-invasive treatments for bladder health, while ensuring comfort and quality of life.
Solace Therapeutics was founded in 1997.
Solace Therapeutics operates in Health Care, Health and Wellness and Medical Devices. Its work centres on bladder health, office-based treatments, non-invasive treatments and patient comfort.
Solace Therapeutics has completed 5 funding rounds, raising a total of $36.00M. The latest funding stage is Series B.
Top alternatives and competitors to Solace Therapeutics include Axonics, Inc., The Urology Group, Tesla Medical s.r.o., Qool Therapeutics, Inc., Caldera Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Solace Therapeutics and Axonics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Solace Therapeutics, https://bouncewatch.com/company/solace-therapeutics, updated 16 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes